A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
- 1 January 1999
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 27 (2) , 127-147
- https://doi.org/10.1023/a:1020670421957
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Assessment of the relative systemic potency of inhaled fluticasone and budesonideEuropean Respiratory Journal, 1996
- Pharmacokinetic/Pharmacodynamic Modeling of Cortisol Suppression after Oral Administration of FluocortoloneThe Journal of Clinical Pharmacology, 1996
- Adrenal Suppression Among Asthmatic Children Receiving Chronic Therapy with Inhaled Corticosteroid with and Without Spacer DeviceAnnals of Allergy, Asthma & Immunology, 1996
- Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonideJournal of Allergy and Clinical Immunology, 1995
- Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled AdministrationThe Journal of Clinical Pharmacology, 1995
- Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in manJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Acute adrenal insufficiency associated with high dose inhaled steroids.BMJ, 1992
- Inhaled Corticosteroids in Asthma: A Dose‐Proportionality Study with Triamcinolone Acetonide AerosolThe Journal of Clinical Pharmacology, 1992
- Pharmacokinetics and Oral Bioavailability of HydrocortisoneThe Journal of Clinical Pharmacology, 1991
- Pharmacokinetics and dose linearity testing of methylprednisolone phosphateBiopharmaceutics & Drug Disposition, 1989